Methylation of Genes in Cervical Cancer Samples
Author Information
Author(s): Aris Spathis, Aga Evaggelia, Alepaki Maria, Chranioti Aikaterini, Meristoudis Christos, Panayiotides Ioannis, Kassanos Dimitrios, Karakitsos Petros
Primary Institution: University General Hospital “ATTIKON”, School of Medicine, Athens, Greece
Hypothesis
Does promoter methylation of p16INK4A, hMLH1, and MGMT correlate with cervical lesion severity and HPV presence?
Conclusion
Promoter methylation of MGMT, hMLH1, and p16INK4A is common in cervical cytology samples, but its accuracy in identifying severe lesions is low.
Supporting Evidence
- Methylation was commonly identified in both benign and pathologic samples.
- MGMT methylation increased significantly with lesion severity.
- p16INK4A protein expression was correlated with MGMT and p16INK4A methylation.
Takeaway
This study looked at how certain genes are changed in cervical cancer samples. They found that while these changes are common, they aren't very good at telling how serious the cancer is.
Methodology
Methylation-specific PCR was used to analyze promoter methylation in liquid-based cytology samples.
Limitations
The study suggests that more data is needed to determine the exact value of methylation status in cervical carcinogenesis.
Participant Demographics
Women with a mean age of 36.8 years, ranging from 18 to 81 years.
Statistical Information
P-Value
P < .0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website